A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.
about
Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at WorkNew small molecule agonists to the thyrotropin receptor.Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodiesThe "TSH Receptor Glo Assay" - A High-Throughput Detection System for Thyroid Stimulation.Update in TSH receptor agonists and antagonistsA small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor ActivationNovel insights on thyroid-stimulating hormone receptor signal transduction.The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis.Allosteric modulators hit the TSH receptor.A selective TSH receptor antagonist inhibits stimulation of thyroid function in female miceA modified ELISA accurately measures secretion of high molecular weight hyaluronan (HA) by Graves' disease orbital cells.Emerging pharmacotherapy for treatment of Graves' diseaseGraves' orbitopathy: imperfect treatments for a rare disease.Current trends in antithyroid drug treatment of Graves' disease.TSHR as a therapeutic target in Graves' disease.Elevated follicular helper T cells and expression of IL-21 in thyroid tissues are involved in the pathogenesis of Graves' disease.
P2860
Q30401802-0086D827-499B-4A5B-80A9-927671F96F85Q34918437-6F07873C-74E6-44E9-B747-DAD91E260057Q35794921-3C4E3528-2CFF-4B4F-9788-1140B2E11B66Q35917939-70CBC8D6-E46B-4FE8-BE39-643D6194A2E6Q36442422-B6D5D22B-3F68-4C9E-B2C8-FEAFCF545948Q36817224-E1C3EF2C-3139-4EF4-8194-FA88A2D9EB3AQ37065722-BB60B81B-EA15-41C0-B257-E57E8EF2394DQ37203610-B0966225-10C6-4C52-8448-5E4347A22F51Q37398299-9AB8982F-A563-437E-81D9-C6098EF57D16Q37405149-8D12683F-7AC3-4A3B-82E2-884E5DA82E75Q37405158-A3336C96-3BE0-4F65-BBD7-8D37ADF4C0F7Q37479329-239FE0BC-84AB-4C23-864E-F93F6DD614AAQ37515491-8C4E281A-978E-4380-8E5E-F1C7CC9EB232Q37582446-FD514FD8-888A-4648-B6D9-80AF6725542CQ38822451-6F2E4C0C-EFEC-4767-87E5-41218CA5F274Q39106190-E6632591-D904-4892-A357-71CC27384230Q53534683-922D302B-2C1E-4D97-B156-BE5D08C6B71A
P2860
A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A drug-like antagonist inhibit ...... n Graves' orbital fibroblasts.
@ast
A drug-like antagonist inhibit ...... n Graves' orbital fibroblasts.
@en
type
label
A drug-like antagonist inhibit ...... n Graves' orbital fibroblasts.
@ast
A drug-like antagonist inhibit ...... n Graves' orbital fibroblasts.
@en
prefLabel
A drug-like antagonist inhibit ...... n Graves' orbital fibroblasts.
@ast
A drug-like antagonist inhibit ...... n Graves' orbital fibroblasts.
@en
P2093
P2860
P356
P1433
P1476
A drug-like antagonist inhibit ...... n Graves' orbital fibroblasts.
@en
P2093
Arthur Pope
Bruce M Raaka
Elizabeth Geras-Raaka
Marvin C Gershengorn
Rebecca S Bahn
Susanne Neumann
P2860
P304
P356
10.1089/THY.2011.0520
P577
2012-07-11T00:00:00Z